Pregabalin in central neuropathic pain associated with spinal cord injury

2006397 citationsJournal Article

Authors

P.J. Siddall · Pfizer (Germany)

Cousins Mj · International Medical Research (Germany)

Andreas Otte · International Medical Research (Germany)

T. Griesing · Pfizer (Germany)

Rachelle Chambers · Pfizer (Germany)

T. K. Murphy · International Medical Research (Germany)

Abstract

Pregabalin 150 to 600 mg/day was effective in relieving central neuropathic pain, improving sleep, anxiety, and overall patient status in patients with spinal cord injury.

Topics & Keywords

Pain Mechanisms and Treatments Anesthesia and Pain Management Musculoskeletal pain and rehabilitation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Neurology

Volume 67, Issue 10, pp. 1792-1800

DOI: 10.1212/01.wnl.0000244422.45278.ff

Field-Weighted Citation Impact: 14.69